Newsletter

195940 - HK inno.N Corporation

195940 Summary
Biopharma
Stock Price & Overview
₩42,050 +300 (+0.72%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩42,050  ≈ US$30  ·  Market cap ₩1.2tn (≈ $851m)
Why this page exists. Korean issuers file to DART, not the SEC, and almost nothing is published in English. Titles here are translated; where kstock has read the filing, the row carries the explanation and the amount in won and dollars. How we pick »

195940 DART Filings

DART

Large business group status disclosure — quarterly, individual company

Filing08/28/26title translated
DART

Supplier Payment Terms and Dispute-Resolution Disclosure

Governance08/14/26title translated
DART

Half-Year Report

Periodic08/14/26title translated
DART

Appointment, dismissal or early departure of an independent director

Filing08/12/26title translated
DART

Results of an extraordinary general meeting

Filing08/12/26title translated
DART

Preliminary operating results (fair disclosure)

Filing07/29/26title translated
DART

Proxy solicitation reference document

Filing07/27/26title translated
DART

Notice of general meeting of shareholders

Filing07/27/26title translated
DART

Advance notice of results disclosure

Filing07/23/26title translated
DART

Resolution to convene an extraordinary general meeting

Filing07/02/26title translated
DART

Record date set, shareholder register closed

Filing07/02/26title translated
DART

Sustainability report (voluntary)

Filing06/30/26title translated
DART

Large business group status disclosure — annual and Q1, individual company

Filing06/01/26title translated
DART

New Facility Investment

Capex05/21/26title translated
DART

Quarterly Report

Periodic05/14/26title translated
DART

Material matter affecting investment judgment (clinical trial plan approval)

Filing05/13/26title translated
3 routine filings (insider holdings reports, IR schedules)DART

Investor Relations Event ×2

IR07/29/26title translated
DART

Investor Relations Event

IR07/02/26title translated
DART

5% Ownership Report — Short Form

Ownership07/01/26title translated
19 filings on file, grouped where one event produced many. Source: DART, operated by Korea's Financial Supervisory Service.

Similar to 195940

SymbolLast Price
006280GC Biopharma Corp.₩127,600
+0.5%
950160Kolon Tissue Gene, Inc.₩17,100
+1.1%
039200Oscotec, Inc.₩36,600
+1.9%
069620Daewoong Pharma₩116,100
+1.1%
290650L & C BIO Co., Ltd.₩47,900
-1.4%
127120JS Link₩33,600
+12.4%
475830Orum Therapeutics, Inc.₩55,900
+2.6%
003090Daewoong Co., Ltd.₩16,860
-2.0%
086450Dong Kook Pharmaceutical Co., Ltd.₩21,600
-0.9%
185750Chong Kun Dang Pharmaceutical Corp.₩68,000
-0.3%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.